Non disponible en dehors du Royaume-Uni et de l'Irlande
Application
Salmeterol xinafoate was used as conjugate with human serum albumin to study the immune responses in rabbits.7
Biochem/physiol Actions
Salmeterol xinafoate is a β2 adrenoceptor agonist with longer lasting bronchodilation and anti-inflammatory effects. It relaxes the airway smooth muscles, stabilizes mast cells and regulates the release of histamine. Salmetrol is particularly effective in treatment of mild asthma, chronic obstructive pulmonary disorder.5,6
β2-adrenoceptor agonist.
Features and Benefits
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
10, 50 mg in glass insert
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :